Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984;13(1):14-8.
doi: 10.1007/BF00401439.

Cytofluorescence localization of adriamycin in resistant colon cancer cells

Cytofluorescence localization of adriamycin in resistant colon cancer cells

B Chauffert et al. Cancer Chemother Pharmacol. 1984.

Abstract

A simple fluorescent microscopic method demonstrated that adriamycin was distributed in two cellular compartments of living rat colon cancer cells. Adriamycin accumulated slowly in cytoplasmic granules, probably lysosomes, where it persisted long after the drug was removed from the medium. On the other hand, adriamycin accumulated rapidly in the nucleus, but was rapidly cleared in adriamycin-free medium. Drug efflux from the nucleus was blocked by sodium azide in glucose-free medium or by verapamil, a calcium-blocking agent. When colon cancer cells were cultivated for 1 day or longer in adriamycin-containing medium no nuclear fluorescence was observed. However, the addition of sodium azide to glucose-free medium or verapamil restores the nuclear fluorescence. The colon cancer cells had low sensitivity to adriamycin, but the addition of verapamil strongly enhanced adriamycin toxicity. Thus adriamycin is permanently cleared from the nucleus of rat colon cancer cells through an energy-dependent efflux mechanism, which is blocked by verapamil. The efficiency of this efflux mechanism is enhanced by exposure of the cell to adriamycin. This mechanism could be involved in the resistance of colon cancer to adriamycin.

PubMed Disclaimer

References

    1. Cancer Res. 1978 Dec;38(12):4722-7 - PubMed
    1. Exp Cell Res. 1977 Feb;104(2):255-62 - PubMed
    1. Cancer Res. 1980 Dec;40(12):4669-76 - PubMed
    1. Cancer Res. 1982 Nov;42(11):4730-3 - PubMed
    1. Cancer Chemother Rep. 1975 Nov-Dec;59(6):1083-9 - PubMed

Publication types